
Development of Vasoactive TherapeuticAward last edited on: 6/18/08
Sponsored Program
STTRAwarding Agency
NIH : NHLBITotal Award Amount
$1,094,965Award Phase
2Solicitation Topic Code
-----Principal Investigator
Colleen M BrophyCompany Information
AzeRx LLC (AKA: Arizona Engineered Therapeutics Inc)
3863 West Park Avenue
Chandler, AZ 85226
Chandler, AZ 85226
(602) 300-1649 |
N/A |
N/A |
Research Institution
----------
Phase I
Contract Number: 1R43HL071309-01Start Date: 00/00/00 Completed: 00/00/00
Phase I year
2002Phase I Amount
$95,000Thesaurus Terms:
biotherapeutic agent, blood vessel transplantation, drug design /synthesis /production, gel, heat shock protein, synthetic peptide, vasoactive agent, vasospasm, vein biomaterial development /preparation, dosage forms, slow release drug, transplant rejection animal tissue, human tissue
Phase II
Contract Number: 2R42HL071309-02A2Start Date: 00/00/00 Completed: 00/00/00
Phase II year
2005(last award dollars: 2006)
Phase II Amount
$999,965Thesaurus Terms:
biotherapeutic agent, blood vessel transplantation, drug design /synthesis /production, gel, heat shock protein, synthetic peptide, vasoactive agent, vasospasm, vein biomaterial development /preparation, dosage forms, slow release drug, transplant rejection animal tissue, human tissue